Production (Stage)
Inozyme Pharma, Inc.
INZY
$3.98
-$0.01-0.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.03% | -14.07% | -8.94% | -13.02% | -11.90% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.53% | -26.99% | 10.55% | 3.28% | 12.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -- |
| Total Current Assets | -22.41% | -14.38% | -7.86% | -12.25% | -11.17% |
|
|
|||||
| Total Current Assets | -22.41% | -14.38% | -7.86% | -12.25% | -11.17% |
| Net Property, Plant & Equipment | -24.37% | -18.67% | -16.46% | -14.17% | -10.96% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -56.12% | 50.85% | 0.00% | 147.27% | -84.49% |
| Total Assets | -22.75% | -14.08% | -7.93% | -12.00% | -11.90% |
|
|
|||||
| Total Accounts Payable | 45.06% | 14.48% | -37.34% | 62.83% | 85.76% |
| Total Accrued Expenses | -20.13% | 37.87% | 4.67% | 18.79% | -26.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.06% | 237.83% | 375.81% | 2.68% | 2.64% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 26.21% | 84.79% | 18.04% | 25.27% | -15.52% |
|
|
|||||
| Total Current Liabilities | 26.21% | 84.79% | 18.04% | 25.27% | -15.52% |
| Long-Term Debt | -34.56% | -25.22% | -7.21% | 0.67% | 0.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -60.86% | -37.37% | -26.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -3.04% | 7.90% | -1.17% | 5.48% | -3.75% |
|
|
|||||
| Common Stock & APIC | 0.47% | 0.50% | 2.94% | 0.61% | 0.43% |
| Retained Earnings | -7.23% | -7.50% | -7.31% | -8.74% | -8.17% |
| Treasury Stock & Other | -107.25% | -62.90% | 280.58% | 1.90% | -356.10% |
| Total Common Equity | -45.01% | -30.15% | -12.32% | -20.55% | -15.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.01% | -30.15% | -12.32% | -20.55% | -15.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.01% | -30.15% | -12.32% | -20.55% | -15.41% |
|
|
|||||